These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34633850)

  • 21.
    Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010.
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3882-8. PubMed ID: 24777091
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Carvalhaes CG; Duncan LR; Wang W; Sader HS
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32778552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020.
    Hawser S; Kothari N; Monti F; Morrissey I; Siegert S; Hodges T
    J Glob Antimicrob Resist; 2023 Jun; 33():304-320. PubMed ID: 37207925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
    Pfaller MA; Mendes RE; Sader HS; Castanheira M; Flamm RK
    J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
    Macone AB; Caruso BK; Leahy RG; Donatelli J; Weir S; Draper MP; Tanaka SK; Levy SB
    Antimicrob Agents Chemother; 2014; 58(2):1127-35. PubMed ID: 24295985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of ceftobiprole and comparator agents when tested against gram-positive and -negative organisms collected across China (2016-2018).
    Dandan Y; Shi W; Yang Y; Yonggui Z; Zhu D; Yan G; Hu F
    BMC Microbiol; 2022 Nov; 22(1):282. PubMed ID: 36435810
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Yang Y; Guo Y; Yin D; Zheng Y; Wu S; Zhu D; Hu F
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms.
    Paukner S; Mendes RE; Arends SJR; Gassner G; Gelone SP; Sader HS
    J Antimicrob Chemother; 2024 Feb; 79(2):360-369. PubMed ID: 38113528
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Morrissey I; Hawser S; Lob SH; Karlowsky JA; Bassetti M; Corey GR; Olesky M; Newman J; Fyfe C
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of ceftaroline against bacterial isolates causing skin and soft tissue and respiratory tract infections collected in Latin American countries, ATLAS program 2016-2020.
    Mohamed N; Valdez RR; Fandiño C; Baudrit M; Falci DR; Murillo JDC
    J Glob Antimicrob Resist; 2024 Mar; 36():4-12. PubMed ID: 38016592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
    Pfaller MA; Flamm RK; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):422-8. PubMed ID: 24445158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Fritsche TR; Stilwell MG; Jones RN
    Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative activities of sitafloxacin against recent clinical isolates in hospitals across China.
    Wu S; Yang Y; Guo Y; Yin D; Zheng Y; Han R; Ding L; Zhu D; Hu F
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2271-2283. PubMed ID: 34013453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015).
    Pfaller MA; Flamm RK; Duncan LR; Streit JM; Castanheira M; Sader HS
    Diagn Microbiol Infect Dis; 2018 May; 91(1):77-84. PubMed ID: 29395713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E; Spiliopoulou I; Kolonitsiou F; Klapsa D; Giannitsioti E; Pantelidi K; Pratti A; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Frantzidou F; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou ED; Petinaki E
    Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.